The Moral Imperative to Include Pregnant Women in Clinical Trials of Interventions for COVID-19.

Malhamé, Isabelle; D'Souza, Rohan; Cheng, Matthew P

Malhamé, Isabelle; D'Souza, Rohan; Cheng, Matthew P.

Malhamé I; McGill University, McGill University Health Centre, and Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada (I.M., M.P.C.).
D'Souza R; Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada (R.D.).
Cheng MP; McGill University, McGill University Health Centre, and Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada (I.M., M.P.C.).

Ann Intern Med ; 173(10): 836-837, 2020 11 17.

Article in English | MEDLINE | ID: covidwho-2110862

Subject(s)

Clinical Trials as Topic/ethics; Coronavirus Infections/drug therapy; Pneumonia, Viral/drug therapy; Pregnancy Complications, Infectious/drug therapy; Pregnant Women; Research Subjects; Antiviral Agents/therapeutic use; Betacoronavirus; COVID-19; Female; Humans; Pandemics; Pregnancy; Pregnancy Complications, Infectious/virology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Pregnancy Complications, Infectious / Clinical Trials as Topic / Coronavirus Infections / Research Subjects / Pregnant Women Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Female / Humans / Pregnancy Language: English Journal: Ann Intern Med Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google